<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17517</article-id><article-id pub-id-type="doi">10.7554/eLife.17517</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group></article-categories><title-group><article-title>eIF2α-mediated translational control regulates the persistence of cocaine-induced LTP in midbrain dopamine neurons</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-43848"><name><surname>Placzek</surname><given-names>Andon N</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">‡</xref></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-48874"><name><surname>Prisco</surname><given-names>Gonzalo Viana Di</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-43845"><name><surname>Khatiwada</surname><given-names>Sanjeev</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-70410"><name><surname>Sgritta</surname><given-names>Martina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-43842"><name><surname>Huang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-56902"><name><surname>Krnjević</surname><given-names>Krešimir</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-56903"><name><surname>Kaufman</surname><given-names>Randal J</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-43847"><name><surname>Dani</surname><given-names>John A</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-30198"><name><surname>Walter</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-43439"><name><surname>Costa-Mattioli</surname><given-names>Mauro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Neuroscience</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Memory and Brain Research Center</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Verna and Marrs McLean Department of Biochemistry and Molecular Biology</institution>, <institution>Baylor College of Medicine</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Physiology</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Degenerative Diseases Program</institution>, <institution>SBP Medical Discovery Institute</institution>, <addr-line><named-content content-type="city">La Jolla</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Department of Neuroscience</institution>, <institution>Mahoney Institute for Neurosciences, Perelman School of Medicine</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">Department of Biochemistry and Biophysics</institution>, <institution>Howard Hughes Medical Institute, University of California at San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Costa</surname><given-names>Rui M</given-names></name><role>Reviewing editor</role><aff id="aff8"><institution>Fundação Champalimaud</institution>, <country>Portugal</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><email>costamat@bcm.edu</email></corresp><fn fn-type="present-address" id="pa1"><label>‡</label><p>Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, United States</p></fn><fn fn-type="con" id="equal-contrib"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>13</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>5</volume><elocation-id>e17517</elocation-id><history><date date-type="received"><day>06</day><month>05</month><year>2016</year></date><date date-type="accepted"><day>13</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Placzek et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Placzek et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-17517-v1.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="article-reference" xlink:href="10.7554/eLife.12056"/><related-article ext-link-type="doi" id="ra2" related-article-type="article-reference" xlink:href="10.7554/eLife.12052"/><abstract><object-id pub-id-type="doi">10.7554/eLife.17517.001</object-id><p>Recreational drug use leads to compulsive substance abuse in some individuals. Studies on animal models of drug addiction indicate that persistent long-term potentiation (LTP) of excitatory synaptic transmission onto ventral tegmental area (VTA) dopamine (DA) neurons is a critical component of sustained drug seeking. However, little is known about the mechanism regulating such long-lasting changes in synaptic strength. Previously, we identified that translational control by eIF2α phosphorylation (p-eIF2α) regulates cocaine-induced LTP in the VTA (Huang et al., 2016). Here we report that in mice with reduced p-eIF2α-mediated translation, cocaine induces persistent LTP in VTA DA neurons. Moreover, selectively inhibiting eIF2α-mediated translational control with a small molecule ISRIB, or knocking down <italic>oligophrenin-1</italic>—an mRNA whose translation is controlled by p-eIF2α—in the VTA also prolongs cocaine-induced LTP. This persistent LTP is mediated by the insertion of GluR2-lacking AMPARs. Collectively, our findings suggest that eIF2α-mediated translational control regulates the progression from transient to persistent cocaine-induced LTP.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.17517.001">http://dx.doi.org/10.7554/eLife.17517.001</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author Keywords</title><kwd>synaptic plasticity</kwd><kwd>psychostimulant abuse</kwd><kwd>protein synthesis</kwd><kwd>AMPAR</kwd><kwd>drug addiciton</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research Organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>DK042394</award-id><principal-award-recipient><name><surname>Kaufman</surname><given-names>Randal J</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>DK088227</award-id><principal-award-recipient><name><surname>Kaufman</surname><given-names>Randal J</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>DK103183</award-id><principal-award-recipient><name><surname>Kaufman</surname><given-names>Randal J</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>CA128814</award-id><principal-award-recipient><name><surname>Kaufman</surname><given-names>Randal J</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000026</institution-id><institution>National Institute on Drug Abuse</institution></institution-wrap></funding-source><award-id>DA09411</award-id><principal-award-recipient><name><surname>Dani</surname><given-names>John A</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>NS21229</award-id><principal-award-recipient><name><surname>Dani</surname><given-names>John A</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Walter</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>MH09816</award-id><principal-award-recipient><name><surname>Costa-Mattioli</surname><given-names>Mauro</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>NS076708</award-id><principal-award-recipient><name><surname>Costa-Mattioli</surname><given-names>Mauro</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.5</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Building on previous work (Huang et al., 2016), we show that translational control by p-eIF2α is a defense mechanism that prevents persistent cocaine-induced synaptic synaptic potentiation underlying compulsive drug seeking.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Drug addiction is a complex behavioral disorder that starts with recreational use and, in some people, progresses to compulsive drug-seeking (<xref ref-type="bibr" rid="bib17">Hyman, 2005</xref>). The precise molecular and cellular mechanism underlying this transition remains unclear. In addicts, repeated drug use leads to long-lasting changes in neuronal structure and function in key reward areas (<xref ref-type="bibr" rid="bib22">Koob and Volkow, 2010</xref>), which have emerged as cellular correlates of drug addiction (<xref ref-type="bibr" rid="bib8">Chen et al., 2008</xref>; <xref ref-type="bibr" rid="bib25">Lüscher and Malenka, 2011</xref>). Of particular interest are excitatory synaptic afferents to dopaminergic neurons in the ventral tegmental area (VTA). These activity-dependent changes in synaptic strength in the VTA constitute the initial synaptic adaptations observed after drug exposure (<xref ref-type="bibr" rid="bib25">Lüscher and Malenka, 2011</xref>; <xref ref-type="bibr" rid="bib32">Schilstrom et al., 2006</xref>). For instance, a single injection of cocaine (or other drugs of abuse) given 24 hr before recording induces an LTP that is manifested as an increase in the ratio of the amplitude of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)- to <italic>N</italic>-methyl D-aspartate receptor (NMDAR)-mediated excitatory postsynaptic currents (EPSCs) onto DA neurons in the VTA (<xref ref-type="bibr" rid="bib38">Ungless et al., 2001</xref>). These early changes in synaptic strength are believed to facilitate persistent alterations in response to repeated exposure to drugs of abuse.</p><p>LTP induced by an acute injection of cocaine typically lasts up to five days, but it returns to baseline after 10 days (<xref ref-type="bibr" rid="bib5">Borgland et al., 2004</xref>). This short-lasting LTP is associated with the insertion of AMPARs lacking the GluR2 subunit, as demonstrated by an increased inward rectification of postsynaptic AMPAR currents (<xref ref-type="bibr" rid="bib4">Bellone and Lüscher, 2006</xref>; <xref ref-type="bibr" rid="bib12">Engblom et al., 2008</xref>). Interestingly, in contrast to passive cocaine administration, LTP persists for several weeks following self-administration (<xref ref-type="bibr" rid="bib8">Chen et al., 2008</xref>). Thus, these drug-induced persistent changes in synaptic strength in the VTA may represent the cellular process driving the progression from recreational to compulsive drug use. Furthermore, pharmacological activation of metabotropic glutamate receptors (mGluRs) with dihydroxyphenylglycine (DHPG), a group I mGluR agonist, inhibits cocaine-induced LTP in VTA DA neurons (<xref ref-type="bibr" rid="bib4">Bellone and Lüscher, 2006</xref>). This inhibition is attributed to the opposing effect of mGluR-mediated long-term depression (mGluR-LTD), which reverses drug-evoked LTP and inward rectification in VTA DA neurons by internalization of AMPARs (<xref ref-type="bibr" rid="bib4">Bellone and Lüscher, 2006</xref>; <xref ref-type="bibr" rid="bib24">Lüscher and Huber, 2010</xref>; <xref ref-type="bibr" rid="bib25">Lüscher and Malenka, 2011</xref>).</p><p>Our recent work provided a unifying model that explains how translational control by phosphorylation of the eukaryotic translation initiation factor eIF2 alpha subunit (eIF2α) regulates these two opposing forms of plasticity (cocaine-induced LTP and mGluR-induced LTD) in the VTA (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>). First, cocaine induces LTP and reduces p-eIF2α levels in the VTA (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>), whereas DHPG elicits mGluR1/5-induced LTD and increases p-eIF2α (<xref ref-type="bibr" rid="bib11">Di Prisco et al., 2014</xref>; <xref ref-type="bibr" rid="bib36">Trinh et al., 2014</xref>). Second, both genetic and pharmacological inhibition of p-eIF2α-mediated translational control facilitates the induction of LTP by blocking mGluR-LTD in VTA DA neurons (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>). Finally, pharmacologically increasing p-eIF2α levels induces mGluR-LTD and prevents cocaine-induced LTP in VTA DA neurons (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>).</p><p>Given that mGluR-LTD blocks the persistence of cocaine-induced LTP (<xref ref-type="bibr" rid="bib27">Mameli et al., 2009</xref>), and our previous finding that p-eIF2α–mediated translational control regulates both forms of long-lasting plasticity (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>), we examined whether the same translational control program regulates the shift from a relatively transient cocaine-induced LTP to a more persistent one in VTA DA neurons.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Single or multiple injections of cocaine reduce eIF2α phosphorylation in the VTA</title><p>Single or repeated exposure to cocaine in rodents induces LTP that lasts for five days, but decays to baseline after 10 days (<xref ref-type="bibr" rid="bib5">Borgland et al., 2004</xref>; <xref ref-type="bibr" rid="bib20">Kauer and Malenka, 2007</xref>; <xref ref-type="bibr" rid="bib27">Mameli et al., 2009</xref>; <xref ref-type="bibr" rid="bib38">Ungless et al., 2001</xref>). To examine the effects of multiple doses of cocaine on p-eIF2α in the VTA, we injected mice with either saline or cocaine (10 mg/kg) once a day for five days and measured the phosphorylation levels of eIF2α in the VTA (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). Interestingly, both acute and repeated exposure to cocaine reduced p-eIF2α levels in the VTA (<xref ref-type="fig" rid="fig1">Figure 1b and c</xref>).<fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.17517.002</object-id><label>Figure 1.</label><caption><title>Acute and repeated exposure to cocaine reduces p-eIF2α levels in the VTA.</title><p>(<bold>a</bold>) Schematic of experimental design. (<bold>b-c</bold>) Both single (10 mg/kg; p&lt;0.001, <italic>n</italic> = 6 per group, <italic>t</italic><sub>10</sub> = 4.640) or multiple (five) injections of cocaine (10 mg/kg, p&lt;0.05, <italic>n</italic> = 3 per group, <italic>t</italic><sub>4</sub> = 4.329) reduced p-eIF2α levels in the VTA of adult mice.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.17517.002">http://dx.doi.org/10.7554/eLife.17517.002</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-17517-fig1-v1"/></fig></p></sec><sec id="s2-2"><title>Cocaine elicits persistent LTP in mice with reduced eIF2α phosphorylation</title><p>We previously showed that the translational program controlled by p-eIF2α regulates the induction of LTP by a single injection of cocaine (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>). To test whether the same process is involved in the persistence of LTP, we first employed <italic>Eif2s1<sup>S/A</sup></italic> heterozygous mutant mice, in which a single phosphorylation site in eIF2α (encoded by the <italic>Eif2s1</italic> gene) at Serine-51 is replaced by alanine. These mice have reduced p-eIF2α levels in the VTA (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>).</p><p>We injected control WT (<italic>Eif2s1<sup>S/S</sup></italic>) and <italic>Eif2s1<sup>S/A</sup></italic> mice with saline or cocaine (10 mg/kg) once a day for three days and recorded glutamate-mediated excitatory postsynaptic currents (EPSCs) from VTA DA neurons in midbrain slices. We measured AMPAR/NMDAR ratios (recorded at +40 mV as we previously described (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib29">Placzek et al., 2016</xref>) 5 and 14 days after cocaine withdrawal. As previously reported (<xref ref-type="bibr" rid="bib5">Borgland et al., 2004</xref>), in control slices, cocaine (10 mg/kg) elicited an LTP that lasted five days (5d) but not 14d after withdrawal (<xref ref-type="fig" rid="fig2">Figure 2a and c</xref>). By contrast, in VTA slices from <italic>Eif2s1<sup>S/A</sup></italic> mice, LTP was greater at five days compared to WT controls and was still present and not significantly changed 14 days after the last cocaine injection (<xref ref-type="fig" rid="fig2">Figure 2b and c</xref>). Indeed, cocaine-induced LTP in the VTA persisted for at least 40 days in <italic>Eif2s1<sup>S/A</sup></italic> mice, which was as long as we continued the withdrawal period (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Thus, a decrease in eIF2α phosphorylation facilitates the progression from transient to persistent cocaine-induced LTP.<fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.17517.003</object-id><label>Figure 2.</label><caption><title>Reduced p-eIF2α levels render cocaine-induced LTP persistent in VTA DA neurons of adult mice.</title><p>(<bold>a–c</bold>) Increased AMPAR/NMDAR ratios lasted only five days in cocaine-injected WT mice (10 mg/kg; 5d, p&lt;0.01, <italic>n</italic> = 11/9/10 saline/5d cocaine/14d cocaine, <italic>F</italic><sub>2,27</sub> = 7.82), but persisted &gt;14 days in cocaine-injected <italic>Eif2s1<sup>S/A</sup></italic> mice (5d, p&lt;0.001; 14d, p&lt;0.001, <italic>n</italic> = 9/8/10 saline/5d cocaine/14d cocaine, <italic>F</italic><sub>2,24</sub> = 13.31). (<bold>d–f</bold>) Similarly, cocaine (10 mg/kg, i.p.) increased AMPAR/NMDAR ratio in GFP-positive cells (in which eIF2α cannot be phosphorylated), both at five and at 14 days post-injection (5d, p&lt;0.001; 14d, p&lt;0.001 , <italic>n</italic> = 5/6/6 saline/5d cocaine/14d cocaine, <italic>F</italic><sub>2,14</sub> = 8.30), compared to control GFP-negative cells (5d, p&lt;0.05, <italic>n</italic> = 5/8/5 saline/5d cocaine/14d cocaine, <italic>F</italic><sub>2,15 </sub>= 4.78) from <italic>Eif2s1<sup>A/A</sup>;</italic>ftg mice.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.17517.003">http://dx.doi.org/10.7554/eLife.17517.003</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-17517-fig2-v1"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.17517.004</object-id><label>Figure 2—figure supplement 1.</label><caption><title>In <italic>Eif2s1<sup>S/A</sup></italic> mice, cocaine induced LTP in VTA DA neurons persisted for 40 days.</title><p>Average AMPAR/NMDAR ratios are shown for adult wild-type control littermates (gray bars, <italic>n = </italic>11/11 saline/40d cocaine) or adult <italic>Eif2s1<sup>S/A</sup></italic> mutant mice (green bars, <italic>n = </italic>9/5 saline/40d cocaine). Forty days after i.p. cocaine injections (10 mg/kg), a significant LTP was observed in VTA DA neurons from <italic>Eif2s1<sup>S/A </sup></italic>mice, but not in control littermates (p&lt;0.05, <italic>n = </italic>11/5 WT 40d cocaine/<italic>Eif2s1<sup>S/A</sup></italic> 40d cocaine, <italic>t</italic><sub>14 </sub>= 2.25, ).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.17517.004">http://dx.doi.org/10.7554/eLife.17517.004</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-17517-fig2-figsupp1-v1"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.17517.005</object-id><label>Figure 2—figure supplement 2.</label><caption><title>Selective absence of eIF2α phosphorylation in VTA enhances persistence of cocaine-induced LTP.</title><p>(<bold>a</bold>) Schematic of experiments. Left: in <italic>Eif2s1<sup>A/A</sup></italic>;ftg mice, both alleles of endogenous gene are mutated (Ser51Ala), and exogenous ftg transgene is expressed containing WT <italic>Eif2s1</italic> and a stop signal flanked by two loxP sites that are followed by EGFP. When neurons are infected with AAV virus expressing Cre, the exogenous WT <italic>Eif2s1</italic> and the stop signal are cleaved by Cre recombinase, enabling the expression of EGFP. Right: illustration of simultaneous recordings from GFP positive and negative VTA neurons</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.17517.005">http://dx.doi.org/10.7554/eLife.17517.005</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-17517-fig2-figsupp2-v1"/></fig></fig-group></p></sec><sec id="s2-3"><title>Conditional reduction in eIF2α phosphorylation specifically in the VTA leads to persistent cocaine-induced LTP</title><p>To assess the regional and temporal specificity of our findings, we used a new eIF2α transgenic mouse line (<italic>Eif2s1<sup>A/A</sup>;</italic>ftg) (<xref ref-type="bibr" rid="bib11">Di Prisco et al., 2014</xref>) characterized by conditional expression of homozygous <italic>Eif2s1</italic> (Ser51Ala) mutants upon cell-type specific recombination mediated by Cre recombinase (<xref ref-type="bibr" rid="bib3">Back et al., 2009</xref>). Cre-mediated deletion of the exogenous <italic>Eif2s1</italic> coding region coordinately induces the expression of green fluorescent protein (GFP) in a small population of VTA neurons, enabling us to manipulate p-eIF2α levels in single cells and record the consequences at the single-cell level (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). In midbrain slices from these mice, we recorded from GFP-positive (GFP+) neurons (in which eIF2α cannot be phosphorylated) and GFP-negative (GFP-) control neurons. As expected, in GFP- (control) VTA DA neurons, cocaine-evoked LTP lasted five days, but returned to baseline by 14 days after withdrawal (<xref ref-type="fig" rid="fig2">Figure 2d and f</xref>). However, in GFP+ VTA DA neurons lacking p-eIF2α, LTP was much greater at five days and persisted for at least 14 days (<xref ref-type="fig" rid="fig2">Figure 2e and f</xref>), highlighting the cell-autonomous effect of eIF2α phosphorylation on the persistence of LTP. It is noteworthy that AAV5-Cre-GFP could infect non-dopaminergic neurons in the VTA of <italic>Eif2s1<sup>A/A</sup>;</italic>ftg mice. However, given the very low titer of virus injected to only sparsely infect DA neurons in the VTA, we expect the effect of inputs from Cre-GFP expressing non-DA neurons to be minimal towards the persistence of LTP in GFP+ VTA DA neurons.</p></sec><sec id="s2-4"><title>Reduced p-eIF2α-mediated translational control leads to persistent cocaine-induced inward rectification</title><p>Cocaine-induced synaptic potentiation in VTA DA neurons is accompanied by a shift in the subunit composition of postsynaptic AMPARs (<xref ref-type="bibr" rid="bib4">Bellone and Lüscher, 2006</xref>). Under normal conditions, postsynaptic AMPA-type currents are mediated by low conductance calcium-impermeable GluR1/GluR2 heteromeric receptors that are characterized by linear AMPAR current-voltage relationships. Exposure to cocaine results in the postsynaptic insertion of high conductance calcium-permeable AMPA receptors that lack GluR2 subunits and are consequently inwardly rectifying (manifested as smaller AMPAR EPSCs measured at positive holding potentials versus those measured at corresponding negative potentials). In addition, GluR2-lacking AMPARs are sensitive to blockade by intracellular polyamines (<xref ref-type="bibr" rid="bib19">Iino et al., 1996</xref>). We therefore sought to determine whether the persistent cocaine-induced LTP that we observed in <italic>Eif2s1<sup>S/A</sup></italic> mice was accompanied by a similarly long-lasting shift in AMPAR subunit composition. By recording EPSCs in VTA DA neurons at −70, 0, and +40 mV to calculate the rectification index, we found that cocaine increased inward rectification in control VTA DA neurons (<italic>Eif2s1<sup>S/S</sup></italic>; <xref ref-type="fig" rid="fig3">Figures 3a,c and e</xref>) and to a greater degree in slices from <italic>Eif2s1<sup>S/A</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figures 3b,d and e</xref>) at five days post-injection. However, 14 days after cocaine treatment, EPSCs were non-rectifying in WT controls (<xref ref-type="fig" rid="fig3">Figures 3a,c and e</xref>), whereas <italic>Eif2s1<sup>S/A</sup></italic> mice retained their inwardly-rectifying properties (<xref ref-type="fig" rid="fig3">Figures 3b,d and e</xref>). Moreover, potentiated EPSCs in cocaine-treated <italic>Eif2s1<sup>S/A</sup></italic> mice measured at 14 days were sensitive to two blockers of GluR2-lacking AMPARs, Joro spider toxin (JST (<xref ref-type="bibr" rid="bib19">Iino et al., 1996</xref>), 500 nM; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a</xref>) and 1-Naphthyl acetyl spermine (NASPM (<xref ref-type="bibr" rid="bib37">Tsubokawa et al., 1995</xref>), 50 μM; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1b</xref>). We conclude that postsynaptic insertion of GluR2-lacking AMPARs underlies the persistent LTP in VTA DA neurons with reduced p-eIF2α levels.<fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.17517.006</object-id><label>Figure 3.</label><caption><title>Reduction of eIF2α phosphorylation enhances the persistence of cocaine-induced AMPAR inward rectification.</title><p>(<bold>a–b</bold>) Representative AMPAR EPSCs traces for each group recorded at −70 and +40 mV. <italic>I-V</italic> plots (<bold>c–d</bold>) and summaries (<bold>e</bold>) illustrate that cocaine-induced rectification lasts only five days in control mice (5d, p&lt;0.001, <italic>n</italic> = 12/10/7 saline/5d cocaine/14d cocaine, <italic>F</italic><sub>2,26 </sub>= 32.02) but persists at least 14 days in <italic>Eif2s1<sup>S/A</sup></italic> mice, (0.001 5d, p&lt;0.0501; 14d, p&lt;0.05, <italic>n</italic> = 8/8/10 saline/5d cocaine/14d cocaine, <italic>F</italic><sub>2,23 </sub>= 17.21).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.17517.006">http://dx.doi.org/10.7554/eLife.17517.006</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-17517-fig3-v1"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.17517.007</object-id><label>Figure 3—figure supplement 1.</label><caption><title>At 14 days post-injection, polyamines inhibit AMPAR EPSCs only in cocaine-treated <italic>Eif2s1<sup>S/A</sup></italic> mice.</title><p>(<bold>a</bold>) At 14 days after cocaine injection, Joro Spider Toxin (JST, 500 nM), a polyamine that blocks GluR2-lacking AMPA current, depressed EPSCs (recorded at −70 mV) in VTA neurons from <italic>Eif2s1<sup>S/A</sup></italic> mice (p&lt;0.001, <italic>n </italic>= 5, <italic>t</italic><sub>8 </sub>= 23.67), but not in neurons from control littermates (p = 0.42, <italic>n </italic>= 5, <italic>t</italic><sub>8 </sub>= 0.857). (<bold>b</bold>) At 14 days after cocaine injection, 1-Naphthyl acetyl spermine (NASPM, 50 μM), a synthetic analog of JST that also blocks GluR2-lacking AMPA current, depressed EPSCs (recorded at −70 mV) in VTA neurons from <italic>Eif2s1<sup>S/A</sup></italic> mice (p&lt;0.01, <italic>n </italic>= 5, <italic>t</italic><sub>8 </sub>= 5.992), but not in neurons from control littermates (p = 0.22, <italic>n = </italic>5, <italic>t</italic><sub>8 </sub>= 1.441).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.17517.007">http://dx.doi.org/10.7554/eLife.17517.007</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-17517-fig3-figsupp1-v1"/></fig></fig-group></p></sec><sec id="s2-5"><title>Selective pharmacological reduction of p-eIF2α-mediated translational control facilitates persistent cocaine-induced LTP and inward rectification</title><p>While phosphorylation of eIF2α inhibits general protein synthesis by inhibiting the guanine nucleotide exchange factor (GEF) eIF2B, it also increases the translation of specific mRNAs (<xref ref-type="bibr" rid="bib7">Buffington et al., 2014</xref>; <xref ref-type="bibr" rid="bib30">Ron and Harding, 2007</xref>). In our previous study, we used the small molecule inhibitor ISRIB, which promotes eIF2B activity resulting in selective reversal of p-eIF2α-mediated translational events (<xref ref-type="bibr" rid="bib33">Sekine et al., 2015</xref>; <xref ref-type="bibr" rid="bib34">Sidrauski et al., 2013</xref>, <xref ref-type="bibr" rid="bib35">2015</xref>) and, consequently, makes adult mice more susceptible to the synaptic and behavioral effects of a sub-threshold dose of cocaine (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>). To determine whether blocking p-eIF2α-mediated translation facilitates the switch from transient to persistent LTP, we administered WT mice with ISRIB (i.p. 2.5 mg/kg) followed by cocaine (10 mg/kg) once a day for three days. Consistent with our findings with <italic>Eif2s1<sup>S/A</sup></italic> mice, cocaine induced both persistent LTP (<xref ref-type="fig" rid="fig4">Figure 4a–c</xref>) and inward rectification (<xref ref-type="fig" rid="fig4">Figure 4d–h</xref>) only in VTA DA neurons from ISRIB-injected mice.<fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.17517.008</object-id><label>Figure 4.</label><caption><title>Reduced p-eIF2α-mediated translation enhances the persistence of cocaine-induced LTP and rectification in VTA DA neurons.</title><p>(<bold>a–c</bold>) Cocaine-induced increase in AMPAR/NMDAR ratios lasted only five days in control mice (5d, p&lt;0.05, <italic>n</italic> = 5/5/5 saline/5d cocaine/14d cocaine, <italic>F</italic><sub>2,12 </sub>= 8.38), but persisted at least 14 days in ISRIB-injected mice (5d, p&lt;0.05; 14d, p&lt;0.05, <italic>n</italic> = 5/5/5 saline/5d cocaine/14d cocaine, <italic>F</italic><sub>2,12 </sub>= 6.40). (<bold>d–e</bold>) Representative AMPAR EPSCs traces and AMPAR/NMDAR ratios. <italic>I-V</italic> plots (<bold>f–g</bold>) and summaries (<bold>h</bold>) illustrate that cocaine-induced rectification lasts only five days in vehicle-injected mice (5d, p&lt;0.05, <italic>n</italic> = 4/4/4 saline/5d cocaine/14d cocaine, <italic>F</italic><sub>2,9 </sub>= 7.12), but persists at least 14 days in ISRIB-injected mice (5d, p&lt;0.05; 14d, p&lt;0.05, <italic>n</italic> = 4/4/4 saline/5d cocaine/14d cocaine, <italic>F</italic><sub>2,9 </sub>= 7.53). (<bold>i</bold>) Knocking down OPHN1 in the VTA prolonged cocaine-induced LTP to 14 days after cocaine withdrawal (p&lt;0.001, <italic>n</italic> = 9/8 control-shRNA/<italic>Ophn1</italic>-shRNA, <italic>t</italic><sub>15 </sub>= 4.986).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.17517.008">http://dx.doi.org/10.7554/eLife.17517.008</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-17517-fig4-v1"/></fig></p><p>Given that p-eIF2α-mediated synthesis of oligophrenin-1 (OPHN1) blocks cocaine-induced LTP (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>), we next asked whether a reduction in OPHN1 levels in the VTA would also prolong cocaine-induced LTP. To answer this question, we knocked-down OPHN1 selectively in the VTA with a specific shRNA (<italic>Ophn1</italic>-shRNA) (<xref ref-type="bibr" rid="bib28">Nadif Kasri et al., 2011</xref>). As expected, in OPHN1-deficient, but not in control VTA DA neurons, cocaine-induced LTP persisted for at least 14 days (<xref ref-type="fig" rid="fig4">Figure 4i</xref>). These data support the notion that cocaine-evoked LTP becomes persistent when p-eIF2α-mediated translation of OPHN1 is repressed.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Drug addiction is a disorder involving maladaptive plasticity in key reward areas of the brain (<xref ref-type="bibr" rid="bib6">Bowers et al., 2010</xref>; <xref ref-type="bibr" rid="bib18">Hyman et al., 2006</xref>; <xref ref-type="bibr" rid="bib20">Kauer and Malenka, 2007</xref>; <xref ref-type="bibr" rid="bib25">Lüscher and Malenka, 2011</xref>). In the VTA, the origin of the mesolimbic dopamine system, single or multiple injections of cocaine evoke synaptic potentiation that persists for about five days. This LTP is generated by the insertion of GluR2-lacking AMPARs into the postsynaptic membrane. Two studies revealed that mGluR-LTD in VTA DA neurons blocks cocaine-evoked LTP in these same cells by replacing GluR2-lacking calcium permeable AMPARs with GluR2-containing receptors (<xref ref-type="bibr" rid="bib4">Bellone and Lüscher, 2006</xref>; <xref ref-type="bibr" rid="bib26">Mameli et al., 2007</xref>). Unlike NMDA-induced LTD, mGluR-LTD depends on new protein synthesis (<xref ref-type="bibr" rid="bib24">Lüscher and Huber, 2010</xref>). We have previously shown that eIF2α-mediated translational control is necessary and sufficient for mGluR-LTD in both the hippocampus and the VTA (<xref ref-type="bibr" rid="bib11">Di Prisco et al., 2014</xref>; <xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>). Translational control by the mammalian target of rapamycin complex 1 (i.e., mTORC1) (<xref ref-type="bibr" rid="bib7">Buffington et al., 2014</xref>; <xref ref-type="bibr" rid="bib10">Costa-Mattioli and Monteggia, 2013</xref>) has also been implicated in mGluR-LTD. Treatment with the mTORC1 inhibitor rapamycin blocks mGluR-LTD in the VTA (<xref ref-type="bibr" rid="bib26">Mameli et al., 2007</xref>). While both translational control mechanisms (mTORC1 and p-eIF2α) could be required for mGluR-LTD, it is possible that rapamycin treatment could affect eIF2α-mediated translational control. During mGluR-LTD, activation of mGluRs by DHPG triggers the synthesis of OPHN1 (<xref ref-type="bibr" rid="bib28">Nadif Kasri et al., 2011</xref>) in a p-eIF2α-dependent manner (<xref ref-type="bibr" rid="bib11">Di Prisco et al., 2014</xref>). If rapamycin exerted its effects on mGluR-LTD by blocking OPHN1 translation, which is required to induce mGluR-LTD (<xref ref-type="bibr" rid="bib11">Di Prisco et al., 2014</xref>; <xref ref-type="bibr" rid="bib28">Nadif Kasri et al., 2011</xref>), these seemingly contradictory findings would be easily reconciled.</p><p>Inhibition of mGluR-LTD by genetic disruption of Homer1C-mGluR1 interaction or by treatment with an antagonist of group I mGluRs [1-aminoindan-1,5-dicarboxylic acid (AIDA)] has been shown to prolong cocaine-induced LTP from five days to seven days (<xref ref-type="bibr" rid="bib27">Mameli et al., 2009</xref>). By suppressing p-eIF2α-mediated mGluR-LTD, we found that cocaine induces an LTP that lasted up to 40 days and was mediated by the insertion of GluR2-lacking receptors. Thus, like self-administration of cocaine (<xref ref-type="bibr" rid="bib8">Chen et al., 2008</xref>), passive injections of cocaine in mice with reduced p-eIF2α-mediated translational control elicit a synaptic potentiation that lasts for weeks.</p><p>Recreational drug use is clinically separable from escalated drug use and compulsive drug-seeking behavior that characterize addiction. Our findings indicate that p-eIF2α-mediated translation prevents the progression from transient to persistent cocaine-induced LTP in VTA DA neurons, thus regulating synaptic potentiation that is believed to underlie compulsive drug seeking (<xref ref-type="bibr" rid="bib8">Chen et al., 2008</xref>; <xref ref-type="bibr" rid="bib25">Lüscher and Malenka, 2011</xref>; <xref ref-type="bibr" rid="bib27">Mameli et al., 2009</xref>). In future studies, it will be interesting to examine whether this translational control mechanism regulates drug-seeking behaviors. In addition, it will important to assess whether cocaine-induced LTP could prime mice for enhanced behavioral output when challenged with a low dose of cocaine (or other drug of abuse) within the persistence window. Finally, it will be intriguing to study whether blocking p-eIF2α-mediated translation with ISRIB during extinction of cocaine memory is sufficient to prevent reinstatement.</p><p>In humans, the vulnerability to compulsive drug abuse has been linked to deficits in cortico-striatal processing (<xref ref-type="bibr" rid="bib13">Ersche et al., 2011</xref>; <xref ref-type="bibr" rid="bib39">Volkow et al., 2009</xref>). We have recently found that mesolimbic neuronal reward responses are altered in human smokers carrying a single nucleotide polymorphism in the <italic>Eif2s1</italic> gene (which encodes eIF2α) (<xref ref-type="bibr" rid="bib29">Placzek et al., 2016</xref>). Therefore, it would be interesting to examine whether cortico-striatal processing is also dysfunctional in these individuals. In this regard, we speculate that in other key reward areas, mice with reduced p-eIF2α-mediated translational control should exhibit synaptic adaptations associated with persistent LTP in the VTA (<xref ref-type="bibr" rid="bib27">Mameli et al., 2009</xref>).</p><p>Finally, in cocaine addicts, persistent activity-dependent changes in synaptic strength in the VTA are likely to produce long-lasting changes in synaptic function in downstream structures, such as the nucleus accumbens (NAc) and prefrontal cortex (PFC). Thus, for a treatment for addiction to be effective, ideally, it should not only target the initial synaptic neuroadaptations in the VTA, but also the synaptic function in other related structures. Given that enhancing mGluR signaling in the NAc blocks cocaine relapse and craving (<xref ref-type="bibr" rid="bib23">Loweth et al., 2013</xref>) and that eIF2α is a key regulator of mGluR-LTD and cocaine-induced LTP, we propose that modulators of p-eIF2α-mediated translational control may be useful in the treatment of cocaine addiction.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mice</title><p>All experiments were conducted using C57Bl/6J male and female mice. <italic>Eif2s1<sup>S/A</sup> and Eif2s1<sup>A/A</sup></italic>;ftg mice were previously described (<xref ref-type="bibr" rid="bib11">Di Prisco et al., 2014</xref>). Mice were kept on a 12 hr/12 hr light/dark cycle (lights on at 7:00 am) and had access to food and water <italic>ad libitum</italic>. Animal care and experimental procedures were approved by the institutional animal care and use committee (IACUC) at Baylor College of Medicine, according to NIH Guidelines.</p><p>No statistical methods were used to predetermine sample sizes. All sample sizes meet the criteria for corresponding statistical tests—our sample sizes are similar to those reported in previous publications (<xref ref-type="bibr" rid="bib1">Argilli et al., 2008</xref>; <xref ref-type="bibr" rid="bib4">Bellone and Lüscher, 2006</xref>; <xref ref-type="bibr" rid="bib21">Koo et al., 2012</xref>; <xref ref-type="bibr" rid="bib31">Saal et al., 2003</xref>; <xref ref-type="bibr" rid="bib38">Ungless et al., 2001</xref>).</p></sec><sec id="s4-2"><title>Drug treatment</title><p>Cocaine was dissolved in 0.9% saline and injected at a volume of 5 ml/kg. Cocaine hydrochloride was obtained from Sigma-Aldrich (St. Louis, MO). ISRIB (P. Walter) was dissolved in DMSO and further diluted in PEG-400 (1:1 ratio) as previously described (<xref ref-type="bibr" rid="bib34">Sidrauski et al., 2013</xref>). For both electrophysiological and behavioral experiments, ISRIB (2.5 mg/kg) or vehicle (DMSO/PEG-400, 2 ml/kg) was injected 90 min before cocaine or saline injection.</p></sec><sec id="s4-3"><title>Slice electrophysiology</title><p>Electrophysiological recordings were performed as previously described (<xref ref-type="bibr" rid="bib16">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib29">Placzek et al., 2016</xref>). The investigators were kept blind to genotypes, and each electrophysiology experiment was replicated at least three times. Briefly, mice were anesthetized with a mixture of ketamine (100 mg/kg), xylazine (10 mg/kg), and acepromazine (3 mg/kg). Mice were transcardially perfused with an ice-cold, oxygenated (95% O<sub>2</sub>/5% CO<sub>2</sub>) solution containing (in mM) NaCl, 120; NaHCO<sub>3</sub>, 25; KCl, 3.3; NaH<sub>2</sub>PO<sub>4</sub>, 1.2; MgCl<sub>2</sub>, 4; CaCl<sub>2</sub>, 1; dextrose, 10; sucrose, 20. Horizontal slices (225–300 μm thick) containing the VTA were cut from the brains of adult (3–5 months old) C57BL/6J mice with a vibrating tissue slicer (VF-100 Compresstome, Precisionary Instruments, San Jose, CA, or Leica VT 1000S, Leica Microsystems, Buffalo Grove, IL). Slices were incubated at 34°C for 40 min, at room temperature for at least 30 min prior to recording, and then transferred to a recording chamber and continuously perfused with oxygenated artificial cerebrospinal fluid (ACSF) at 32°C and a flow rate of 2–3 ml/min. The recording ACSF was identical to the cutting solution except for the concentration of MgCl<sub>2</sub> (1 mM) and CaCl<sub>2</sub> (2 mM). Recording pipettes were made from thin-walled borosilicate glass (TW150F-4, WPI, Sarasota, FL), which were filled with intracellular solution containing (in mM): 117 CsMeSO3; 0.4 EGTA; 20 HEPES; 2.8 NaCl, 2.5 ATP-Mg 2.0; 0.25 GTP-Na; 5 TEA-Cl, adjusted to pH 7.3 with CsOH and 290 mOsmol/l; tip resistance, 3–5 MΩ. For studies of AMPAR current rectification, spermine (100 μM) was added to the internal solution.</p><p>Data were obtained with a MultiClamp 700B amplifier, digitized at 20 kHz with a Digidata 1440A, recorded by Clampex 10 and analyzed with Clampfit 10 software (Molecular Devices), and filtered online at 4 kHz with a low-pass Bessel filter. A 2 mV hyperpolarizing pulse was applied before each EPSC to evaluate the input (R<sub>i</sub>)and access resistances (R<sub>a</sub>). Data were not included if R<sub>a</sub> was either unstable or greater than 25 MΩ, holding current was &gt;200 pA, R<sub>i</sub> dropped &gt;20% during the recording, or EPSC baselines changed by &gt;10%. The representative traces illustrated in Figures are averages of 10–15 consecutive recorded sweeps.</p><p>After establishing a gigaohm seal (&gt;2 GΩ) and recording stable spontaneous firing in cell-attached, voltage clamp mode (−70 mV holding potential), cell phenotype was determined by measuring the width (&gt;1.0 ms) of the cell-attached action potential (<xref ref-type="bibr" rid="bib9">Chieng et al., 2011</xref>; <xref ref-type="bibr" rid="bib14">Ford et al., 2006</xref>). AMPAR/NMDAR ratios were calculated as previously described (<xref ref-type="bibr" rid="bib38">Ungless et al., 2001</xref>). Briefly, neurons were voltage-clamped at +40 mV until the holding current stabilized (at &lt;200 pA), which usually occurred after a period of 5 to 15 min. A bipolar stimulating electrode placed 50–150 μm rostral to the lateral VTA was used to evoke stable monosynaptic EPSCs at 0.05 Hz. Picrotoxin (100 μM) was added to the recording ACSF to block GABA<sub>A</sub>R-mediated IPSCs. After recording the dual-component EPSC, bath-application of DL-AP5 (100 μM for 10 min) was used to remove the NMDAR component, which was then obtained by offline subtraction of the remaining AMPAR component from the original dual-component EPSC. The peak amplitudes of the isolated currents were used to calculate the AMPAR/NMDAR ratios. Rectification indices were calculated as the ratio of the chord conductance of evoked EPSCs at a negative holding potential (−70 mV) to the chord conductance obtained from recordings made at a positive holding potential (+40 mV) in the presence of 100 μM DL-AP5, as previously described (<xref ref-type="bibr" rid="bib4">Bellone and Lüscher, 2006</xref>). Joro spider toxin (JST) was obtained from Sigma-Aldrich (St. Louis, MO), Picrotoxin and DL-AP5 were purchased from Tocris Bioscience, and all other reagents and experimental compounds were obtained from Sigma-Aldrich.</p></sec><sec id="s4-4"><title>Virus injection</title><p>AAV5-Cre (Titer: 1.0e13GC/ml) was purchased from Vector Biolabs (Cat#7012, Philadelphia, PA); Lentiviral constructs expressing <italic>Ophn1</italic> shRNA and scrambled shRNA were generously provided by Dr. Linda van Aelst (<xref ref-type="bibr" rid="bib28">Nadif Kasri et al., 2011</xref>) and viruses were produced by Gene Vector Core Laboratory (Baylor College of Medicine). Viral injections were performed as previously described (<xref ref-type="bibr" rid="bib11">Di Prisco et al., 2014</xref>). Briefly, mice were anaesthetized with isoflurane (2–3%) and viruses (1–2 μl/site) were injected bilaterally at the rate of 0.1 μl/min, and an additional 10 min to allow for diffusion of viral particles. Injection coordinates targeting the VTA were as follows (with reference to bregma): −2.50 AP, ± 0.45 ML, −4.50 DV. The incision was sutured after injection and mice were returned to home cages. Mouse body weight and signs of illness were monitored until full recovery from surgery (~1 week). Drug treatment and experiments were all performed at least three weeks after viral injection.</p></sec><sec id="s4-5"><title>Statistical analyses</title><p>All data are presented as mean ± s.e.m. Statistical analyses were performed using SigmaPlot (Systat Software). Data distribution normality and homogeneity of variance were assessed using the Shapiro-Wilk and Levene tests, respectively. The statistics were based on the two-sided Student’s t test, or one- or two-way ANOVA with Tukey’s HSD (or HSD for unequal sample sizes where appropriate) to correct for multiple <italic>post hoc</italic> comparisons. Within-groups variation is indicated using standard errors of the mean of each distribution, which are depicted in the graphs as error bars. p&lt;0.05 was considered significant (*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Hongyi Zhou for assisting in the maintenance of mouse colony and members of the Costa-Mattioli laboratory for comments on the paper. This work was supported by grants from the National Institutes of Health (NIMH 096816, NINDS 076708) and the generous support from Sammons Enterprises. RJK is supported by NIH grants DK042394, DK088227, DK103183 and CA128814. JAD was supported by grants NIH NIDA DA09411 and NINDS NS21229. PW is an investigator of the Howard Hughes Medical Institute.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>ANP, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con2"><p>GVDP, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con3"><p>SK, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con4"><p>MS, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con5"><p>WH, Conception and design, Acquisition of data</p></fn><fn fn-type="con" id="con6"><p>KK, Drafting or revising the article</p></fn><fn fn-type="con" id="con7"><p>RJK, Drafting or revising the article, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con8"><p>JAD, Conception and design, Drafting or revising the article</p></fn><fn fn-type="con" id="con9"><p>PW, Conception and design, Drafting or revising the article</p></fn><fn fn-type="con" id="con10"><p>MC-M, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animal care and experimental procedures were approved by the institutional animal care and use committee (IACUC) at Baylor College of Medicine (Protocol number: AN-5068), according to NIH Guidelines.</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argilli</surname><given-names>E</given-names></name><name><surname>Sibley</surname><given-names>DR</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>England</surname><given-names>PM</given-names></name><name><surname>Bonci</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>9092</fpage><lpage>9100</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1001-08.2008</pub-id><pub-id pub-id-type="pmid">18784289</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbach</surname><given-names>BD</given-names></name><name><surname>Osterweil</surname><given-names>EK</given-names></name><name><surname>Bear</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mutations causing syndromic autism define an axis of synaptic pathophysiology</article-title><source>Nature</source><volume>480</volume><fpage>63</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/nature10658</pub-id><pub-id pub-id-type="pmid">22113615</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Back</surname><given-names>SH</given-names></name><name><surname>Scheuner</surname><given-names>D</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><name><surname>Ribick</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Gildersleeve</surname><given-names>RD</given-names></name><name><surname>Pennathur</surname><given-names>S</given-names></name><name><surname>Kaufman</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Translation attenuation through eIF2alpha phosphorylation prevents oxidative stress and maintains the differentiated state in beta cells</article-title><source>Cell Metabolism</source><volume>10</volume><fpage>13</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2009.06.002</pub-id><pub-id pub-id-type="pmid">19583950</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellone</surname><given-names>C</given-names></name><name><surname>Lüscher</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression</article-title><source>Nature Neuroscience</source><volume>9</volume><fpage>636</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1038/nn1682</pub-id><pub-id pub-id-type="pmid">16582902</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borgland</surname><given-names>SL</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Bonci</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats</article-title><source>Journal of Neuroscience</source><volume>24</volume><fpage>7482</fpage><lpage>7490</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1312-04.2004</pub-id><pub-id pub-id-type="pmid">15329395</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowers</surname><given-names>MS</given-names></name><name><surname>Chen</surname><given-names>BT</given-names></name><name><surname>Bonci</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future</article-title><source>Neuron</source><volume>67</volume><fpage>11</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.06.004</pub-id><pub-id pub-id-type="pmid">20624588</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffington</surname><given-names>SA</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Costa-Mattioli</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Translational control in synaptic plasticity and cognitive dysfunction</article-title><source>Annual Review of Neuroscience</source><volume>37</volume><fpage>17</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-071013-014100</pub-id><pub-id pub-id-type="pmid">25032491</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>BT</given-names></name><name><surname>Bowers</surname><given-names>MS</given-names></name><name><surname>Martin</surname><given-names>M</given-names></name><name><surname>Hopf</surname><given-names>FW</given-names></name><name><surname>Guillory</surname><given-names>AM</given-names></name><name><surname>Carelli</surname><given-names>RM</given-names></name><name><surname>Chou</surname><given-names>JK</given-names></name><name><surname>Bonci</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA</article-title><source>Neuron</source><volume>59</volume><fpage>288</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2008.05.024</pub-id><pub-id pub-id-type="pmid">18667156</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chieng</surname><given-names>B</given-names></name><name><surname>Azriel</surname><given-names>Y</given-names></name><name><surname>Mohammadi</surname><given-names>S</given-names></name><name><surname>Christie</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area</article-title><source>The Journal of Physiology</source><volume>589</volume><fpage>3775</fpage><lpage>3787</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2011.210807</pub-id><pub-id pub-id-type="pmid">21646409</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa-Mattioli</surname><given-names>M</given-names></name><name><surname>Monteggia</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>mTOR complexes in neurodevelopmental and neuropsychiatric disorders</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>1537</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1038/nn.3546</pub-id><pub-id pub-id-type="pmid">24165680</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Prisco</surname><given-names>GV</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Buffington</surname><given-names>SA</given-names></name><name><surname>Hsu</surname><given-names>CC</given-names></name><name><surname>Bonnen</surname><given-names>PE</given-names></name><name><surname>Placzek</surname><given-names>AN</given-names></name><name><surname>Sidrauski</surname><given-names>C</given-names></name><name><surname>Krnjević</surname><given-names>K</given-names></name><name><surname>Kaufman</surname><given-names>RJ</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name><name><surname>Costa-Mattioli</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Translational control of mGluR-dependent long-term depression and object-place learning by eIF2α</article-title><source>Nature Neuroscience</source><volume>17</volume><fpage>1073</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1038/nn.3754</pub-id><pub-id pub-id-type="pmid">24974795</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engblom</surname><given-names>D</given-names></name><name><surname>Bilbao</surname><given-names>A</given-names></name><name><surname>Sanchis-Segura</surname><given-names>C</given-names></name><name><surname>Dahan</surname><given-names>L</given-names></name><name><surname>Perreau-Lenz</surname><given-names>S</given-names></name><name><surname>Balland</surname><given-names>B</given-names></name><name><surname>Parkitna</surname><given-names>JR</given-names></name><name><surname>Luján</surname><given-names>R</given-names></name><name><surname>Halbout</surname><given-names>B</given-names></name><name><surname>Mameli</surname><given-names>M</given-names></name><name><surname>Parlato</surname><given-names>R</given-names></name><name><surname>Sprengel</surname><given-names>R</given-names></name><name><surname>Lüscher</surname><given-names>C</given-names></name><name><surname>Schütz</surname><given-names>G</given-names></name><name><surname>Spanagel</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Glutamate receptors on dopamine neurons control the persistence of cocaine seeking</article-title><source>Neuron</source><volume>59</volume><fpage>497</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2008.07.010</pub-id><pub-id pub-id-type="pmid">18701074</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ersche</surname><given-names>KD</given-names></name><name><surname>Barnes</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>PS</given-names></name><name><surname>Morein-Zamir</surname><given-names>S</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name><name><surname>Bullmore</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence</article-title><source>Brain</source><volume>134</volume><fpage>2013</fpage><lpage>2024</lpage><pub-id pub-id-type="doi">10.1093/brain/awr138</pub-id><pub-id pub-id-type="pmid">21690575</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>CP</given-names></name><name><surname>Mark</surname><given-names>GP</given-names></name><name><surname>Williams</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>2788</fpage><lpage>2797</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4331-05.2006</pub-id><pub-id pub-id-type="pmid">16525058</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Klann</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression</article-title><source>Journal of Neuroscience</source><volume>24</volume><fpage>6352</fpage><lpage>6361</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0995-04.2004</pub-id><pub-id pub-id-type="pmid">15254091</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Placzek</surname><given-names>AN</given-names></name><name><surname>Viana Di Prisco</surname><given-names>G</given-names></name><name><surname>Khatiwada</surname><given-names>S</given-names></name><name><surname>Sidrauski</surname><given-names>C</given-names></name><name><surname>Krnjević</surname><given-names>K</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name><name><surname>Dani</surname><given-names>JA</given-names></name><name><surname>Costa-Mattioli</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Translational control by eIF2α phosphorylation regulates vulnerability to the synaptic and behavioral effects of cocaine</article-title><source>eLife</source><volume>5</volume><elocation-id>e12052</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.12052</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Addiction: a disease of learning and memory</article-title><source>American Journal of Psychiatry</source><volume>162</volume><fpage>1414</fpage><lpage>1422</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.162.8.1414</pub-id><pub-id pub-id-type="pmid">16055762</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname><given-names>SE</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Neural mechanisms of addiction: the role of reward-related learning and memory</article-title><source>Annual Review of Neuroscience</source><volume>29</volume><fpage>565</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.29.051605.113009</pub-id><pub-id pub-id-type="pmid">16776597</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iino</surname><given-names>M</given-names></name><name><surname>Koike</surname><given-names>M</given-names></name><name><surname>Isa</surname><given-names>T</given-names></name><name><surname>Ozawa</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Voltage-dependent blockage of Ca(2+)-permeable AMPA receptors by joro spider toxin in cultured rat hippocampal neurones</article-title><source>The Journal of Physiology</source><volume>496</volume><fpage>431</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1996.sp021696</pub-id><pub-id pub-id-type="pmid">8910227</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kauer</surname><given-names>JA</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Synaptic plasticity and addiction</article-title><source>Nature Reviews Neuroscience</source><volume>8</volume><fpage>844</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1038/nrn2234</pub-id><pub-id pub-id-type="pmid">17948030</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>JW</given-names></name><name><surname>Mazei-Robison</surname><given-names>MS</given-names></name><name><surname>Chaudhury</surname><given-names>D</given-names></name><name><surname>Juarez</surname><given-names>B</given-names></name><name><surname>LaPlant</surname><given-names>Q</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Scobie</surname><given-names>KN</given-names></name><name><surname>Damez-Werno</surname><given-names>D</given-names></name><name><surname>Crumiller</surname><given-names>M</given-names></name><name><surname>Ohnishi</surname><given-names>YN</given-names></name><name><surname>Ohnishi</surname><given-names>YH</given-names></name><name><surname>Mouzon</surname><given-names>E</given-names></name><name><surname>Dietz</surname><given-names>DM</given-names></name><name><surname>Lobo</surname><given-names>MK</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name><name><surname>Han</surname><given-names>MH</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>BDNF is a negative modulator of morphine action</article-title><source>Science</source><volume>338</volume><fpage>124</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1126/science.1222265</pub-id><pub-id pub-id-type="pmid">23042896</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koob</surname><given-names>GF</given-names></name><name><surname>Volkow</surname><given-names>ND</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Neurocircuitry of addiction</article-title><source>Neuropsychopharmacology</source><volume>35</volume><fpage>217</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1038/npp.2009.110</pub-id><pub-id pub-id-type="pmid">19710631</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loweth</surname><given-names>JA</given-names></name><name><surname>Tseng</surname><given-names>KY</given-names></name><name><surname>Wolf</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Using metabotropic glutamate receptors to modulate cocaine's synaptic and behavioral effects: mGluR1 finds a niche</article-title><source>Current Opinion in Neurobiology</source><volume>23</volume><fpage>500</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2013.01.009</pub-id><pub-id pub-id-type="pmid">23385114</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lüscher</surname><given-names>C</given-names></name><name><surname>Huber</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease</article-title><source>Neuron</source><volume>65</volume><fpage>445</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.01.016</pub-id><pub-id pub-id-type="pmid">20188650</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lüscher</surname><given-names>C</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling</article-title><source>Neuron</source><volume>69</volume><fpage>650</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.01.017</pub-id><pub-id pub-id-type="pmid">21338877</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mameli</surname><given-names>M</given-names></name><name><surname>Balland</surname><given-names>B</given-names></name><name><surname>Luján</surname><given-names>R</given-names></name><name><surname>Lüscher</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area</article-title><source>Science</source><volume>317</volume><fpage>530</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1126/science.1142365</pub-id><pub-id pub-id-type="pmid">17656725</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mameli</surname><given-names>M</given-names></name><name><surname>Halbout</surname><given-names>B</given-names></name><name><surname>Creton</surname><given-names>C</given-names></name><name><surname>Engblom</surname><given-names>D</given-names></name><name><surname>Parkitna</surname><given-names>JR</given-names></name><name><surname>Spanagel</surname><given-names>R</given-names></name><name><surname>Lüscher</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>1036</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1038/nn.2367</pub-id><pub-id pub-id-type="pmid">19597494</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadif Kasri</surname><given-names>N</given-names></name><name><surname>Nakano-Kobayashi</surname><given-names>A</given-names></name><name><surname>Van Aelst</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rapid synthesis of the X-linked mental retardation protein OPHN1 mediates mGluR-dependent LTD through interaction with the endocytic machinery</article-title><source>Neuron</source><volume>72</volume><fpage>300</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.001</pub-id><pub-id pub-id-type="pmid">22017989</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Placzek</surname><given-names>AN</given-names></name><name><surname>Molfese</surname><given-names>DL</given-names></name><name><surname>Khatiwada</surname><given-names>S</given-names></name><name><surname>Viana Di Prisco</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Sidrauski</surname><given-names>C</given-names></name><name><surname>Krnjević</surname><given-names>K</given-names></name><name><surname>Amos</surname><given-names>CL</given-names></name><name><surname>Ray</surname><given-names>R</given-names></name><name><surname>Dani</surname><given-names>JA</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name><name><surname>Salas</surname><given-names>R</given-names></name><name><surname>Costa-Mattioli</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Translational control of nicotine-evoked synaptic potentiation in mice and neuronal responses in human smokers by eIF2α</article-title><source>eLife</source><volume>5</volume><elocation-id>e12056</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.12056</pub-id><pub-id pub-id-type="pmid">26928076</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Harding</surname><given-names>HP</given-names></name></person-group><year iso-8601-date="2007">2007</year><chapter-title>eIF2alpha phosphorylation in cellular stress responses and disease</chapter-title><person-group person-group-type="editor"><name><surname>Mathews</surname> <given-names>M. B</given-names></name><name><surname>Sonenberg</surname> <given-names>N</given-names></name><name><surname>Hershey</surname> <given-names>J. W. B</given-names></name></person-group><source>Translational Control in Biology and Medicine</source><publisher-loc>Cold Spring Harbor, NY</publisher-loc><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name><fpage>345</fpage><lpage>368</lpage></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saal</surname><given-names>D</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Bonci</surname><given-names>A</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons</article-title><source>Neuron</source><volume>37</volume><fpage>577</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(03)00021-7</pub-id><pub-id pub-id-type="pmid">12597856</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schilström</surname><given-names>B</given-names></name><name><surname>Yaka</surname><given-names>R</given-names></name><name><surname>Argilli</surname><given-names>E</given-names></name><name><surname>Suvarna</surname><given-names>N</given-names></name><name><surname>Schumann</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>BT</given-names></name><name><surname>Carman</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Mailliard</surname><given-names>WS</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Bonci</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>8549</fpage><lpage>8558</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5179-05.2006</pub-id><pub-id pub-id-type="pmid">16914681</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname><given-names>Y</given-names></name><name><surname>Zyryanova</surname><given-names>A</given-names></name><name><surname>Crespillo-Casado</surname><given-names>A</given-names></name><name><surname>Fischer</surname><given-names>PM</given-names></name><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Stress responses. Mutations in a translation initiation factor identify the target of a memory-enhancing compound</article-title><source>Science</source><volume>348</volume><fpage>1027</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1126/science.aaa6986</pub-id><pub-id pub-id-type="pmid">25858979</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sidrauski</surname><given-names>C</given-names></name><name><surname>Acosta-Alvear</surname><given-names>D</given-names></name><name><surname>Khoutorsky</surname><given-names>A</given-names></name><name><surname>Vedantham</surname><given-names>P</given-names></name><name><surname>Hearn</surname><given-names>BR</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Gamache</surname><given-names>K</given-names></name><name><surname>Gallagher</surname><given-names>CM</given-names></name><name><surname>Ang</surname><given-names>KK</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Okreglak</surname><given-names>V</given-names></name><name><surname>Ashkenazi</surname><given-names>A</given-names></name><name><surname>Hann</surname><given-names>B</given-names></name><name><surname>Nader</surname><given-names>K</given-names></name><name><surname>Arkin</surname><given-names>MR</given-names></name><name><surname>Renslo</surname><given-names>AR</given-names></name><name><surname>Sonenberg</surname><given-names>N</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pharmacological brake-release of mRNA translation enhances cognitive memory</article-title><source>eLife</source><volume>2</volume><elocation-id>e00498</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.00498</pub-id><pub-id pub-id-type="pmid">23741617</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sidrauski</surname><given-names>C</given-names></name><name><surname>Tsai</surname><given-names>JC</given-names></name><name><surname>Kampmann</surname><given-names>M</given-names></name><name><surname>Hearn</surname><given-names>BR</given-names></name><name><surname>Vedantham</surname><given-names>P</given-names></name><name><surname>Jaishankar</surname><given-names>P</given-names></name><name><surname>Sokabe</surname><given-names>M</given-names></name><name><surname>Mendez</surname><given-names>AS</given-names></name><name><surname>Newton</surname><given-names>BW</given-names></name><name><surname>Tang</surname><given-names>EL</given-names></name><name><surname>Verschueren</surname><given-names>E</given-names></name><name><surname>Johnson</surname><given-names>JR</given-names></name><name><surname>Krogan</surname><given-names>NJ</given-names></name><name><surname>Fraser</surname><given-names>CS</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name><name><surname>Renslo</surname><given-names>AR</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response</article-title><source>eLife</source><volume>4</volume><elocation-id>e07314</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.07314</pub-id><pub-id pub-id-type="pmid">25875391</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinh</surname><given-names>MA</given-names></name><name><surname>Ma</surname><given-names>T</given-names></name><name><surname>Kaphzan</surname><given-names>H</given-names></name><name><surname>Bhattacharya</surname><given-names>A</given-names></name><name><surname>Antion</surname><given-names>MD</given-names></name><name><surname>Cavener</surname><given-names>DR</given-names></name><name><surname>Hoeffer</surname><given-names>CA</given-names></name><name><surname>Klann</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The eIF2α kinase PERK limits the expression of hippocampal metabotropic glutamate receptor-dependent long-term depression</article-title><source>Learning &amp; Memory</source><volume>21</volume><fpage>298</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1101/lm.032219.113</pub-id><pub-id pub-id-type="pmid">24741110</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsubokawa</surname><given-names>H</given-names></name><name><surname>Oguro</surname><given-names>K</given-names></name><name><surname>Masuzawa</surname><given-names>T</given-names></name><name><surname>Nakaima</surname><given-names>T</given-names></name><name><surname>Kawai</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Effects of a spider toxin and its analogue on glutamate-activated currents in the hippocampal CA1 neuron after ischemia</article-title><source>Journal of Neurophysiology</source><volume>74</volume><fpage>218</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">7472325</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ungless</surname><given-names>MA</given-names></name><name><surname>Whistler</surname><given-names>JL</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Bonci</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons</article-title><source>Nature</source><volume>411</volume><fpage>583</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1038/35079077</pub-id><pub-id pub-id-type="pmid">11385572</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname><given-names>ND</given-names></name><name><surname>Fowler</surname><given-names>JS</given-names></name><name><surname>Wang</surname><given-names>GJ</given-names></name><name><surname>Baler</surname><given-names>R</given-names></name><name><surname>Telang</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Imaging dopamine's role in drug abuse and addiction</article-title><source>Neuropharmacology</source><volume>56 (Suppl 1)</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.05.022</pub-id><pub-id pub-id-type="pmid">18617195</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.17517.010</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Costa</surname><given-names>Rui M</given-names></name><role>Reviewing editor</role><aff id="aff9"><institution>Fundação Champalimaud</institution>, <country>Portugal</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;eIF2α-mediated translational control regulates the persistence of cocaine-induced LTP in midbrain dopamine neurons&quot; for consideration by <italic>eLife</italic>. Your article has been favorably evaluated by a Senior Editor and two reviewers, one of whom, Rui M Costa (Reviewer #2), is a member of our Board of Reviewing Editors.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>The study is seen as very interesting, but there are a few points to check before it can be considered further.</p><p>The authors should clarify the effects on total eIF2α p-eIF2α levels, provide evidence or discuss the specificity of their manipulation, and check if similar effects are observed with another drug (NASPM is suggested).</p><p>A direct link between eIF2α and OPHN, or a correlating between LTP at 14 days and behavior would be great additions, but are long experiments and so if the authors already have some data they could add it, otherwise these aspects could be touched upon in the Discussion.</p><p>Below are the specific comments to help prepared the revised submission.</p><p><italic>Reviewer #1:</italic> </p><p>This is a very interesting study, also perhaps a little bit on the brief side for <italic>eLife</italic>. The findings seem to support the conclusions, but the manuscript would benefit a lot from a direct link of the physiology to cocaine's behavioral effects, even just simple locomotor activity or sensitization.</p><p>For <xref ref-type="fig" rid="fig1">Figure 1</xref>, was there a significant difference in the total eIF2α and p-eIF2α levels, or was the effect only significant for the ratio of p-eIF2α/total eIF2α?</p><p>For the AAV5-Cre-GFP virus injection into the VTA of eIF2α floxed mice, it is not clear whether the effect is mediated by selective knockdown of expression in VTA neurons, let alone DA neurons, as AAV5-Cre has strong retrograde activity. The authors should consider a way to knock it down from DA neurons selectively (i.e. crossing to DAT-Cre mouse) or state the caveat of the AAV5-Cre approach as non-specific to VTA.</p><p>JST is not the canonical drug utilized to block GluA2-lacking AMPA receptors. It would be important to see if similar effects are observed with NASPM.</p><p>A direct link between eIF2α and OPHN1 would make the study's final conclusion much more convincing. For example, overexpressing OPHN1 in eIF2α mutants should rescue heightened, long-lasting LTP.</p><p><italic>Reviewer #2:</italic> </p><p>This Research Advance builds on previous findings by the same group, and helps elucidate the role of eIF2α in cocaine-induced plasticity in the ventral tegmental area. The authors find that single or repeated injections of cocaine lead to reduced levels of eIF2α phosphorylation in the ventral tegmental area. Furthermore they confirm that cocaine administration elicits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopaminergic neurons that lasts at least 5 days but decays to baseline after 14 days. However, in mice with reduced eIF2α phosphorylation the potentiation is long-lasting and persist even after 14 days.</p><p>The authors then show that selective pharmacological reduction of eIF2α mediated translation has the same has the same effect and facilitates persistent cocaine-induced LTP even after 14 days. The authors have previously shown that eIF2α-mediated synthesis of OPHN1 blocks cocaine-induced LTP. So finally, here they confirmed that cocaine-induced LTP persisted for 14 days in OPHN1-deficient, but not in control VTA DA neurons.</p><p>These findings add mechanistic insight to the previous findings, are very well done and lead to straightforward conclusions. The only thing to add (if the authors would already have it) would be a behavioral correlate of the 14 days persistent LTP in the conditions applied here (before animals in the different groups were sacrificed).</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.17517.011</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>[…] The study is seen as very interesting, but there are a few points to check before it can be considered further.</italic> </p><p><italic>The authors should clarify the effects on total eIF2α p-eIF2α levels, provide evidence or discuss the specificity of their manipulation, and check if similar effects are observed with another drug (NASPM is suggested).</italic> </p><p><italic>A direct link between eIF2α and OPHN, or a correlating between LTP at 14 days and behavior would be great additions, but are long experiments and so if the authors already have some data they could add it, otherwise these aspects could be touched upon in the Discussion.</italic> </p><p>To our knowledge, the best behavioral correlate of persistent LTP of excitatory synaptic transmission onto VTA DA neurons is compulsive drug-seeking behavior (see Mameli et al., Nat Neurosci, 2009; Chen et al., Neuron, 2008). Unfortunately, the self-administration procedure in mice is very technically challenging and would take well beyond the two months allowed by the journal for resubmission. While interesting, we believe that the study of whether p-eIF2α -mediated translational control regulates compulsive drug-seeking behavior is beyond the scope of this study. That said, we now address this issue in the Discussion section (third paragraph). In future studies, we plan to assess whether reduced p-eIF2α -mediated translation in the VTA precipitates compulsive cocaine seeking.</p><p><italic>Below are the specific comments to help prepared the revised submission.</italic> </p><p><italic>Reviewer #1:</italic> </p><p><italic>This is a very interesting study, also perhaps a little bit on the brief side for eLife. The findings seem to support the conclusions, but the manuscript would benefit a lot from a direct link of the physiology to cocaine's behavioral effects, even just simple locomotor activity or sensitization.</italic> </p><p><italic>For <xref ref-type="fig" rid="fig1">Figure 1</xref>, was there a significant difference in the total eIF2α and p-eIF2α levels, or was the effect only significant for the ratio of p-eIF2α/total eIF2α?</italic> </p><p>We examined the effect of chronic cocaine treatment on both p-eIF2α and total eIF2α levels and found that only the levels of phosphorylated eIF2α significantly change in response to cocaine. New representative figures are now provided (<xref ref-type="fig" rid="fig1">Figure 1B-C</xref>).</p><p><italic>For the AAV5-Cre-GFP virus injection into the VTA of eIF2α floxed mice, it is not clear whether the effect is mediated by selective knockdown of expression in VTA neurons, let alone DA neurons, as AAV5-Cre has strong retrograde activity. The authors should consider a way to knock it down from DA neurons selectively (i.e. crossing to DAT-Cre mouse) or state the caveat of the AAV5-Cre approach as non-specific to VTA.</italic> </p><p>As suggested by the reviewer, we now discussed the technical limitation of using AAV5-Cre to excise the floxed WT eIF2α transgene in the VTA (subsection “Conditional reduction in eIF2α phosphorylation specifically in the VTA leads to persistent cocaine-induced LTP”).</p><p><italic>JST is not the canonical drug utilized to block GluA2-lacking AMPA receptors. It would be important to see if similar effects are observed with NASPM.</italic> </p><p>We agree with the reviewer’s comment. As suggested, we have now performed a new set of experiments in which we examined the effect of NASPM on AMPAR- mediated EPSCs in slices from <italic>Eif2s1<sup>S/S</sup></italic>and <italic>Eif2s1<sup>S/A</sup></italic>mice. Consistent with the JST results, NASPM blocked AMPAR-mediated EPSC in slices from <italic>Eif2s1<sup>S/A</sup></italic>mice, but not in slices from <italic>Eif2s1<sup>S/S</sup></italic>mice (see new <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Thus, these data further support the conclusion that the persistent LTP in <italic>Eif2s1<sup>S/A</sup></italic>mice is due to the insertion of GluR2-lacking AMPARs on the synaptic surface.</p><p><italic>A direct link between eIF2α and OPHN1 would make the study's final conclusion much more convincing. For example, overexpressing OPHN1 in eIF2α mutants should rescue heightened, long-lasting LTP.</italic> </p><p>In our previous paper (Huang et al., <italic><underline>eLife,</underline> </italic>2016), we provided causal evidence that the effects of eIF2α phosphorylation on cocaine-induced LTP are mediated, at least in part, by OPHN1. We showed that Sal003, which promotes phosphorylation of eIF2α, blocks cocaine-induced LTP in control neurons, but not in neurons in which OPHN1 levels are reduced.</p><p>While we agree that overexpressing OPHN1 should prevent the persistence of LTP in <italic>Eif2s1<sup>S/A</sup></italic>mice, we are concerned that overexpressing OPHN1 might lead to changes in basal synaptic transmission as has been previously reported (Kasri et al., JN, 2009) and might occlude cocaine-induced LTP.</p></body></sub-article></article>